Featured publications

• The SOX11:SMARCA4 complex is a driver of oncogenic transcriptional programs in mantle cell lymphoma

  De Bolos, Anna; Carreras-Caballe, Maria; Sureda-Gomez, Marta; Rodriguez, Marta-Leonor; Charalampopoulou, Stella;

  (...)

  Martin-Subero, Jose, I; Campo, Elias; Reverter, David; Villanueva, Josep; Amador, Virginia.

  See complete list of authors

  Reference:

  Blood Cancer Journal 2025.

• SOX11 expression is restricted to EBV-negative Burkitt lymphoma and is associated with molecular genetic features

  Sureda-Gómez, M; Iaccarino, I; De Bolòs, A; Meyer, M; Balsas, P;

  (...)

  Leoncini, L; Campo, E; Siebert, R; Amador, V; Klapper, W.

  See complete list of authors

  Reference:

  Blood 2024.

• SOX11/PRDX2 axis modulates redox homeostasis and chemoresistance in aggressive mantle cell lymphoma (vol 14, 7863, 2024)

  De Bolos, Anna; Sureda-Gomez, Marta; Carreras-Caballe, Maria; Rodriguez, Marta-Leonor; Clot, Guillem;

  Bea, Silvia; Gine, Eva; Campo, Elias; Balsas, Patricia; Amador, Virginia.

  Reference:

  Scientific Reports 2024.

• SOX11 is a novel binding partner and endogenous inhibitor of SAMHD1 ara-CTPase activity in mantle cell lymphoma

  Morsy, MHA; Lilienthal, I; Lord, M; Merrien, M; Wasik, AM;

  (...)

  Taylor, IA; Christensson, B; Campo, E; Herold, N; Sander, B.

  See complete list of authors

  Reference:

  Blood 2024.

• SOX11/PRDX2 axis modulates redox homeostasis and chemoresistance in aggressive mantle cell lymphoma

  De Bolòs, A; Sureda-Gómez, M; Carreras-Caballé, M; Rodríguez, ML; Clot, G;

  Beà, S; Giné, E; Campo, E; Balsas, P; Amador, V.

  Reference:

  Scientific Reports 2024.

• Tumorigenic role of Musashi-2 in aggressive mantle cell lymphoma

  Sureda-Gómez, M; Balsas, P; Rodríguez, ML; Nadeu, F; De Bolòs, A;

  (...)

  Jares, P; Martín-Subero, J; Beà, S; Campo, E; Amador, V.

  See complete list of authors

  Reference:

  Leukemia 2023.

• SOX11, CD70 and Treg cells configure the tumor immune microenvironment of aggressive mantle cell lymphoma

  Balsas, Patricia; Veloza, Luis; Clot, Guillem; Sureda-Gomez, Marta; Rodriguez, Marta-Leonor;

  (...)

  Engel, Pablo; Quintanilla-Martinez, Leticia; Klapper, Wolfram; Campo, Elias; Amador, Virginia.

  See complete list of authors

  Reference:

  Blood 2021.

• Impaired ribosome biogenesis checkpoint activation induces p53-dependent MCL-1 degradation and MYC-driven lymphoma death

  Domostegui, A; Iannizzotto, F; Garcia-Cajide, M; Kozma, SC; Gentilella, A;

  (...)

  Kelly, GL; Salazar, R; Kusnadi, EP; Kang, J; Pearson, RB.

  See complete list of authors

  Reference:

  Blood 2021.

• Increased Tumor Angiogenesis in SOX11-positive Mantle Cell Lymphoma

  Petrakis, Georgios; Veloza, Luis; Clot, Guillem; Gine, Eva; Gonzalez-Farre, Blanca;

  (...)

  Martinez, Antonio; Lopez-Guillermo, Armando; Amador, Virginia; Ribera-Cortada, Inmaculada; Campo, Elias.

  See complete list of authors

  Reference:

  Histopathology 2019.

• Selective BTK inhibition improves bendamustine therapy response and normalizes immune effector functions in chronic lymphocytic leukemia

  Lee-Verges, Eriong; Hanna, Bola S; Yazdanparast, Haniyeh; Rodriguez, Vanina; Leonor Rodriguez, Marta;

  (...)

  Perez-Galan, Patricia; Lopez-Guerra, Monica; Campo, Elias; Seiffert, Martina; Colomer, Dolors.

  See complete list of authors

  Reference:

  International Journal Of Cancer 2019.